Companies: 10,795·Total market cap: $144.5T

Propanc Biopharma, Inc.

Propanc Biopharma, Inc.

PPCBNASDAQHealthcare● Active

$1.42

+$0.05(+3.39%)

Market Cap$1238547

P/E Ratio—

52W High$270.25

52W Low$1.31

Avg Volume134K

Open$1.38

Beta3.29

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Propanc Biopharma, Inc.（PPCB）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · PPCB · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-33.00Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding158,727.04Shares outstanding history

Next EarningsTBAEarnings history

探索 Propanc Biopharma, Inc. 数据

分析师预测—

股息不分红

盈利EPS $-371.25+98.95%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$58.9M▼ 3135.77% YoY

202320242025

FY 2025EPS$-371.25▲ +98.95% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$18.4MEPS: $-33.00View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Propanc Biopharma, Inc.

$1.42+3.39%$1.2M #2

Cell Source, Inc.

$0.82+2.50%$36.9M #3

Gemina Laboratories Ltd.

$0.05+0.00%$3.8M #4

HOOKIPA Pharma Inc.

$1.15+0.00%$14.4M #5

EOM Pharmaceuticals Holdings, Inc.

$0.27+27.02%$30.6M #6

PreveCeutical Medical Inc.

$0.01+0.00%$6.6M

股票表现

1D+5.84%

1W-19.89%

1M-34.68%

3M-66.28%

YTD-89.20%

1Y-99.23%

5Y-99.96%

关于 Propanc Biopharma, Inc.

CEOJames Nathanielsz

IPO DateNov 12, 2012

Employees1

CountryAU

Websitepropanc.com

Propanc Biopharma, Inc. (PPCB) is an Australian biopharmaceutical firm dedicated to developing innovative treatments for various cancers, with a particular focus on pancreatic, ovarian, and colorectal…

Biotechnology HealthcareNASDAQAU

关于股票概览与关键数据

Propanc Biopharma, Inc.（PPCB）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 12, 2012 在 NASDAQ 上市。截至最近交易日，PPCB 股价为 $1.42，市值约为 $1.2M。过去12个月累计回报 -99.23%，年初至今回报 -89.20%。

2025 财年 Propanc Biopharma, Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Propanc Biopharma, Inc.（PPCB）股价为 $1.42，在 NASDAQ 上市，52周区间为 $1.31 – $270.25。

PPCB 最新股价PPCB quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议